Clinical Study | Office of Clinical Research

Safety, Tolerability And Activity Of Ibudilast (Mn-166) In Subjects With Progressive Multiple Sclerosis.

Posted Date: May 15, 2019

Investigator: Aram Zabeti
Type of Study: Drug

The study will be conducted by the NeuroNEXT Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) in about 28 sites around the United States. We are doing this research study to find out if the drug ibudilast can help people with progressive multiple sclerosis (MS). We will also find o

Criteria:

You Are Being Asked To Take Part In This Study Because You Have Been Diagnosed With A Progressive Fo

Keywords:

Secondary Progressiv, Multiple Sclerosis, Primary Progressive, Ms, Ibudilast

For More Information:

Alecia Boehl
513-558-0039
alecia.boehl@uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List